Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
<h4>Background</h4>Her2 expression and amplification occurs in a significant subset of gastro-esophageal carcinomas. Her2 is a client protein of molecular chaperones, e.g. heat shock protein (HSP) 90, rendering targeted therapies against Her2/HSP90 an interesting approach. This study aim...
Guardado en:
Autores principales: | Sabina Berezowska, Alexander Novotny, Karina Bauer, Annette Feuchtinger, Julia Slotta-Huspenina, Karen Becker, Rupert Langer, Axel Walch |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e834074fe05a43dba62b96084fc7a1dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas.
por: Julia Slotta-Huspenina, et al.
Publicado: (2012) -
Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer
por: Thomas Kunzke, et al.
Publicado: (2021) -
HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
por: Toshiki Kijima, et al.
Publicado: (2018) -
The Hsp90 machinery facilitates the transport of diphtheria toxin into human cells
por: Manuel Schuster, et al.
Publicado: (2017) -
Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
por: Zhi Peng, et al.
Publicado: (2021)